Lorillard
Cancer,Inc.
Fields
- Author
- Rosenbaum, R.
- Type
- NEWS, NEWSPAPER ARTICLE
- PHOT, PHOTOGRAPH
- Area
- PUBLIC RELATIONS FILE ROOM
- Named Organization
- Abbott Lab
- Ama, Ama
- American Assn for Cancer Research
- American Cancer Research Center + H
- American Cancer Society
- American College of Radiologists
- British Assn for Cancer Research
- Ca A Cancer Journal for Clinicians
- Calorie Control Council
- Cancer Letter
- Colgate Palmolive
- Comm on Quackery
- Comm on Unproven Methods of Cancer
- Congress
- Eastern Cooperative Oncology Group
- Eli Lilly
- Eppley Inst
- Extract Mfg Assn
- FDA, Food and Drug Administration
- Foote Cone + Belding
- General Accounting Office
- General Foods
- Health Research Group
- Hew, Dept of Health Education and Welfare
- House Appropriations Comm
- House Subcomm on Health + Environme
- Lancet
- Litton Industries
- Miles Lab
- Nas, Natl Academy of Sciences
- Nasa
- Natl Cancer Advisory Board
- NCI, Natl Cancer Inst
- New Scientist
- NIH, Natl Inst of Health
- Office of Cancer Communications
- Pennwalt
- Proctor + Gamble
- Royal Crown Cola
- Subcomm on En
- Thomas A Edison Industries
- Univ of Buffalo
- Univ of Wi
- Va Commonwealth Univ
- Wa Post
- Warner Lambert
- Ama, Ama
- Site
- N24
- Named Person
- Allen, J.R.
- Ames, B.
- Arje, S.
- Bailar, J. III
- Bobst, E.
- Clark, L.
- Coley, B.
- Davis, A.
- Delaney
- Deters, J.
- Dixon, F.
- Farber, S.
- Fink, D.
- Foote, E.
- Ford
- Garb, S.
- Garfinkel
- Gould, D.
- Hammond, E.C.
- Hodgkin
- Holleb, A.
- Hoover, R.
- Jones, W.
- Lasker, A.
- Lasker, M.
- Letton, H.
- Morrison, B.
- Nader, R.
- Newell, G.
- Nixon, R.
- Nobel
- Obey, D.
- Olson, K.
- Pomerance, W.
- Rauscher, F.
- Regelson, W.
- Rhoads, J.
- Rimer, I.
- Sager, R.
- Schmidt, B.
- Shubik, P.
- Stringfellow, G.
- Temin, H.
- Upton, A.C.
- Vannevel, P.
- Watson, J.
- Wilm
- Yarborough, R.
- Zelen, M.
- Zinder
- Ames, B.
- Request
- R1-273
- Author (Organization)
- New Times
- Litigation
- Feda/Produced
- Date Loaded
- 15 Mar 2002
- UCSF Legacy ID
- byd74c00
Document Images
problem~ much. earlier)can undetermined
number of womem in the program, duz-
enscountedalready, have: had their
breastss removed without there having
been any trace of cancer.
It was typical of the slapdash man-
nerim whioh; the joint ACS/NCI program
wasininiated tMatt early questionss about
thee fatal potential of repeated mammog-
raphy were totallyignored, as were re-
search fihdings published well!before the
program began, which,, yearsJater., were
to resultt inn complete' revision of the
screening guidelines for younger wom-
en.. "We just didn't doo ourr homework
the way we shouldl have," said NC[ As-
sistant Director Dr. B'ayardMbrrison,
thee only administrator who concedes
negligence.
Those directly responsible for
NCFs part in the program-De. Diane
Fink, Directorr of the NCI. Division of
Cancer Control and'. RehabJ;itation (also
on the ACS board of directors until re-
cently): Dr. Frank Rauscher: then NCI
Director andlDr. Guy Newell, NCI Act.
ing Director in the program's later
stages-insist they hadl no reason to sus-
pect',
there was any seriouss question of
radiation: risk until 1975. AtACS the
official amnesia runs on till'. 1976:. But
NCI's own files clearly expose these fee:-
ble.lies.. Among many early memos and
letters sent to Dr..Frank Rauscher(now
ACSSenior Vice President for R'e«
search) was one by Dr. Newell himself',
dated October 1973, only a few months
after thescreening, project'hadt begun,
Responding to ACS:'s suggestion.that the
number of screening centers be in-
creased from,20 to27, Newell wrote::."I
cannot inalln good' consciousness[sic]
agree to, this unless some specific con-
cerns and'.questionsare addressed and
answeredi asto thee safety of repeated
mamm ography by an e xpert group."
But.am ever-obedient NCI adminisn tration agreed to shell out more taxpay-
er's.money forthe extra. centers..while
giviugnot.a thoughtt to.the appoihtment
of even one radiation biology expert-
especially irresponsible considering that:
the studyoni whiehthe screening pro-
gram was based. conducted! by the.
Health Insurance Plan of Greater NewYork,. showed absolutely no, benefit too
women under 50, who made up 50 per-
cennof the program participants, and for
whom anyadded riskk would have:a long-
ertime to play.itself out..
In.adlfiiionto the radliation problem:,
somescientists, after carefW analysis:, 0
'.
questionedl the validity oflthe.program it-~
self:. "The projectis ill-conceived and is
not likely to resulnin significant patien0.~benefit," wrote Dr,. Marvin Zelen, then ~
Professor of Statistics at Uhiversity of ~;
Buffalo. And Dr. lohn. Bailar. III,, then ~NCI.Deputy Associate Director for Can-
cer Control, expressed doubt whether
anything;at alllcould: be learned about re-
ducing breast cancermonalit5t'consider-
img the projecds lack of proper research
design.
Responding to~ all these criticisms:,
in a..confidential in-housee memto,, breast
surgeon and ACS Senior Vice President
for Medical Affairs, Dr. Arthur Holleb,,
conceded: "I d'o nott feell qualified to an,
swer with statisticall expertise." Yet he
went on to.denigratethe critics with pa-
thetic ad hominem argumentssuch, as: "I
am always suspicious of' the man who
comments on a:breast cancerpro'ject and
refers to the anatomic site ass the
'bresn."' referring to:a typo in one.of thecritic:'s letters.
The idea for thescreening program
originated:witb ACSI It was first on a lisn
of suggestionssents to NCI by Dr.. Hol-
leb, shortly after the National Cancer
Act was passed, as to how the newCanrcer Control Program, money (whichACS'.
had lobbied for) should bee spent.
Though NCI agreedftom, thebegin-
ning,to fund abouo 85 ' percent of thef54.6, milfion project, ACShascom-manded every detail, backed
bythe
AmericanCollege ofi Radiologists.
As Dr. Kenneth Olson,, formerly
Chiefof Diagnosis of NCI's; Diviaion of
Cancer Biology, explained in a1973.
memo: . "This project. has limited . objec-
tivesand theyy havebeen pretty much.
dictated byACS. In summarytheyarer.
Can ACS volunteers mobilize a.largea number (100,000 per year) of women for
thermography., mammography. and a
physical examihation?. . . This rather
endsthe objectives. ..
While not bothering to establish
adequate research protocoll (though afollow-upstud!y was planned) or to re-
view previous researchfindings.. ACS'S
took great.careto seee that the 27 centerss
weree distributed! evenly over itsfund'.raisingzones and that the centers them-
selves refrained from fund-raising,so as,
not tocut into ACS profits..
BENh1 nhl NO
At each challenge to the program,.
ACS and other mammography propo-
nentsresponded nott witK scientific rea-
soning butt withh professional arrogance.
NCI Chiefof CancerDiagnosisDri.
NdilliamPomerance,. tried'd to persuadee
screening center: directors, many oBwhom aree affiliated: with ACS or theA;merican College of
Radiolbgists,, to,
raise the minimum age for x-ray scneen-ingfrom 355 to 45. "They all fell on me,"
he reported., "and even went so far'as to
d'ecideih their protocol they wouldlstarl:
with age 30., 1 know thatatt this moment
their reaction ishysteria butt thereyoue have it. .... . It does.give you an idea as
tothetenor ofthemedical profes-sion. . . ."
As thecontlroversye became moreheated, women participating inthen pro-
gram were not even informed that tliterewos a,.controversy-the word "risk:" did
4

not: appear on the informed consent
sheets until May 1976,and was not.clear-
ly described to them until May 1977.
Meanwhile, not even the simplest
precautions were takenn to keep x-ray ex-
posure toa minimum. A.report byRalph
Nader's,Health Research Group showed
that 33-or 55.pereent-of the x-ray ma-
chines surveyed in 1975 emitted more
than the:acceptabfe:limit.of 2.5Roentgens
per film;; in 1976. I I centers weree stil I ex-
posing women: to.dangerousdoses.of x-
rays.. This meant that.,, evenn for thou-
sand's of women ouer 50,, mammography
could result in greaterrisk.than.benefit,
as one of three expert groups.,., finally
appointedby. NCII. suggested in a March
'77 report. Belate& as itt was,, the expert
groups' appointment was not. even ini-
tiated, by NCII directors,: but: wasthe re-
sultt of effortsby Dr. John Bailar who.
after a fruitless 3-year barrage of ACS
and NCII directors' oftices,, brought the
question.of rad'iation risk to the public.in
a paper presented before the.American
Assoc. for Cancer Research.. Thecon-
clusions of the expert groups,, basedchiefly on. the same November 1972 Na.
tionaf Academyy of Sciences reporb. ("Bi'-ological Effects: of Ionizing. Radiationi')
than Bailar and othershad reffered to,
eonfirmed'that asymptomatic women unt
der 50, shouldlnot neceive:repeated x-ray
screening unless they had a personal or
family history of breast canc er..
While publicity generated by the ex:-
perts:" reports forced the NCI to shift
sluggishly from~ passive negligence to
sincere effortstos modify screening
procedures. ACS. along with the Ameri-
can College of Radiologists;, attempted
to sabotage thesee effontss and tokeep~
women ignorantt of the experts' eonclb-
sions:
Alugust 1976: A letter from NCI
based on the panel'spreliminaryreporrs was sent to.all screening center diiectors.s
advising them to, . restrictt x-ray screening of womenunder 50~ Severallrefused tocomply., publicly
referring too thee newguiidelinesw
as "so much more govern-
ment gobbledygook" and "Potomac Fe:-ver" One source reportedl that center di~
rectors calling ACS'.for advice were toldd
to"Go ahead and screen: 'emn" and too
justify. their dbingso by certainn loop-
holes in the guidelines, loopholeswhicb
ACSwasreponedly responsible for in-
serting. In the fallowingsix months.75~.
percent of'f women under 500 were stil I' being
x-rayed.
Septemher 1976:. The New YorkCity division of ACS circulated over
15.000 copies of'ani "Urgent Message to.
Women," whichadvisedl women under
5ortoundergo mammographyifi they fell
into one or more of several risk catego-ries. By ACS's:own accountthese risk
categories.include 80.percent of alllwom-
en.under 50. While ACS'officials denied
that their national office had anything to
do. with itt it was just a rambunctious
act byy one of their madcap local
branches-Dr. Hollebhimself told me
that hehad personally approved the
Message and, he adtiedI proudly, "I'd
still stand behind it."Cn fact he:'0 wriaten
an, editoriall for the Nov. / Dec. issue ofACS's Ca:. A Cancer Journatfor C7tni-
cians, the medical journal withthe:larg-h estt circulation in the worfd, that made.
just about.the same points~as were madee
in the U'rgentM'essage.
March 1977: NCIVs OfficeoNCancer
Communications, under Paul Van Nevel',, prepared.a press release to announce
thee conclusions of the expertt groups.
Rather thamrtelease it.on thedate.expect-
edl,. Drs. Fink and'~ Newelli and Mr. Van:
Nevellwent.to New York City to consult
with ACS, Theresultinge press release
consisted of' wishy-washy doublbtalkk
bearing little resembiance: to~ anything.
the.expertshad written. ThoughDr: Ne+well d'eniedi before a~congressionalisub-
committee. this summer that any change
had been made.in the originall release
other than the date. Idr. Fink Ikter adtnit-
ted to me that "certain parts of the re-
pon'ss summaryhad,tobeleft.out"after
"vigorous discussion" with,ACS.
Curuurm to orusadurs
Mention. "National Cancer Insti:
tute" tomost people, even in Bethesda,.
Maryland (NCI headquarters), and'd
youi B probably be "corrected": "Youu
mean,.the American Cancer Society."
ACS power and'd atHuencedependse on.its being recognized as the sole dis-pensen of eancerinformation
and hope,.,
and as the sime qua non of any eventuall
cancer cure. Their firstt big publicityblitz'y was launched in 1945 by ad4ertising,
magnate Albert Lasker, his wife Mary,
now honorary chairmann of the ACS
board of directors, and Emerson Foote,
co.founder of the. Foote, Cone and Beld-
ing advertising agency. They hired apro-fessional fund-raiser and persuaded'd
prime-time broadtasters to~ speak aboutt
the: horrorss ofcancer and our only
hopes-a checkk and a checkup. 'p'he:
April fund-raising crusade was immedi-
ately effective. Im its: second year, $10
million was gleaned from a newly can-
cer-aware American public. Since then,.
ACS has becomethee wealthiest of thee
health charity groups,, itsofficialss thehighest.paid, and'. with, its image as.thecaneer-fighting
organization in the coun-try,. is not aboutt to sitt back andl watch
things change~
A formen employee of'NCIrs Office
of Cancer Communications, specifically
charged.by Congress "to disseminate in-
formation to:the practiicing:physician and
to the general public," toldime of'.the dis-
integration of theentite Program L.iai-
son. Branch, basically because of ACS
interference.
"WHen NCI getss recognition for
some piece of public information, ACS
doesn't.like in. Sometimes we'd be at.the
eleventh hour with the budget and every-
thingg approved byy our superiors, and
suddenly. there'd be a meetling scheduled
with.ACS in. NewYork.. Their Public. In-
formation and Education people would
have objections toit,o and that~ was the
end- Or they'd have us.dobusy work,
like run tests.on messages or think again
whether we shoultb say 'Us Against Can-
cer'or'We AgainsCCancer.'"
Eventually ir was nothing, against
cancer, and after 4 or 5' frustrating years,
thee branch's four staff, members left: for
other jobs:and have not been replaced.
Why would an NCI Division Direc-
tor, i~n this case Mr. Paul V an Nevel, in-
sisn that his staff consultfirst with ACS?
An:NCllsource.from another.departtment
explains: "Ifl' you make waves, someone
will get in touch with someone else and
before you know it Mary Lasker saysto
.,

Life Memibers. who act.as consultantsto
the board'.f of directors. At. NCII, several
members ofl the advisory board ac6 as
consultants to industrial firms. The most
notable, Phillipe. Shubik was private
consultant and scientific adMisorto Gen-
eral Foods, Proctor & Gamble, Abbott
Lab~, MilesLab., Royal Crown Cola
Co.. Colgate-Palmolive. Co:., the . Exaract
ManufaeturersAssociation,. andrthe Cal-
orie Control Council, during the time he
served as chairman of the NCI.subcom-
mittee on Environmental Carcinogene-
sis..Iu a: dispute over the.carcinogenicity
of a particular chemical manufactured
by Proctor and Gamble, Shubik was
asked byanotheri NCI scientist.no state
whom he wasspeaking:for. "Proctorand
Gamble." Shubikreplied, without Poesi-
tation.
No wonder, them,t that. smoking, al-
cohol and excessive sunlight are the
main environmental targets forthe . selec-
tive: cancer-fighterss at ACS: and'. NCII-
reduetion in exposure depends safely on
a change in specific personal habitsnot
in the habits of industcy,, chief producer
of chemical carcinogens,.
Maligning the tobacco industry or
citing a few workplace.carcinogens like
asbestos an& vinyl chloride still doesnwt
place imquestionthe practice of'f pouring
thousands of newchemicals, untested,
unmonitored,, intothe environment ev- whether apregnanta woman, should att
ery year: Among, thosee already pro- least avoid eating}hemostcontaminated~
duced,, nearly 2',p0o.are on a government species of fish:
list oflsuspected carcinogens. "Thati fishh is very good for your
NCI's bioassay (chemical. test) wife ., .. It might be one op thee best
branch was to have.tested and reported thingsshecouldieatin.hercondition..Thes on severalhundtedl of
these by now; in- fish you buy inn a. regular fish. storee or a
steadl it has becomea testimony to the: regular supermarket will noti bee con-
adminiistration's.lackof support for this taminated. I assure you-shopp in aregu-
linea of attackk on cancer. So, fewstaff, . larfish storeand'you'II have noproblem
membersweres assigned toahe branchatall."
thatt testing, reportsCongressman.Obey,. You'd like to think that this was an
was "turned over too a complex web ofi isolated case-a single irresponsible ex.outside research
firms who are, for thee ecutive who hassomething against ir-
mostt part.. privatee businesses that are: regular fish stores. But fierce protective-also,
contracting.with the industriesthati ness toward.dangerous chemicals istypi:
manufacture these chemicals, and incal' of the top administrators at ACS and'
some cases are onvned' outright by theNCI.
chemical manufacturingcosnpanies."' For instance, while an FIDA agent
Thecareinogenesis program's originall told me they regularly find residues o8director resigned IIg8
monthsago.,s fol-several different pesticiHes~ includingg
lowed by his. assistant, chiefly because: DDT in food,. Dr.. Frank Rauscher as-
they could' not tackle unassisted the ev- sured me, "Wedon't havee any pestir
er-increasing backlog of unevaluatedl cidesshowing up ini the food' chain any- R
chemical tests.. Now that backlogg has more.. DDT was thought.to bee a reasonr
reached over 200,. and in the: pastt twoo ably potent carcinogen in mart, but wee
years,reports on: only 14chemicals.have. Just don't have that anymore." Poof.
been issued.(A review of'f theInstitute:'s. Among food color additives alone'.,,
approach to environmentafl causes of there are 4suspected and 2 known:car-cancer hass been initiated
by recently cinogens, as a Health Research Groupp
appointedNCI Director Dr. Arthur C:. reportt based on FDA files revealedL.Yet
Upton.) Dr. Rauscher and Dr. Lee Clark recently
wrote:in the WashingtonBost.: "There is.
ACS, with; its provenn influence: oveunor evidencee totmplicate food'd preserva:-Congress:..iis in a
uniqueposition toinflu, tives or additives now onthemarket in,
ence national policy om eancer-causinghumamcancer .. .. chemicals:.. Yett they have
eonsistentlyM~eanwhile,. ACS has been sniping,
refused to give effecnive.support tocru-away'at the-0elaneyClause, the public'ss
cial biflssuchas the Toxic Substancesmaindefense, weak as itist against car.Control Act, the Cleani
Air~ Acn and a.a cinogens in: food. Despite public state:-proposall toban DES, a.known carcino-
ments to the contrary. I was told by Lar.gen,
ftomcatult:feed: ry Garfinkel, Dr. Hammond'sassistant
"ACSS will send a IetteraS supportt that ACS would.liketo see the Delaneyafter a bill hasalready
beem passed by Clausemodifiedlso that it.would be.more.
Congress,"an employee: of the Housedfilhculte totakeo legislative actionn on,
subcotmmicteee on Healthandl Environ-efiemicals- based on animal test results.
mentt nold me. "Butt they'vee neverr been, "There should be some human epidemi-of any real help,,
except on smoking leg- ological evidence presentt before a sub.islation." stance is bannedl,"
Garfinkel said.
Perhaps worsethan legislative in-BLt asDr:. Robert Hoover., NCII
ertia is ACS' betrayal ofYhe trust of in-HCeadlof the Environmental Studies. See-
dividuals,, whoo call their public informa, tion of Environmental Epidemiology
nion service.expecting to.be given the lat- explains, "Youhave.to use animalstud-est available
information.. ies and sound biological reasoning.
Consider the question ofthe. "saBe-That'sall we have. short:of placingahrge.
ty" ofi polychlorinated biphenyls segments of the.population att risk." Be-(PCBs)-a potent
carcinogeniand terano-cause of cancer's 20-to-30-year latency
gen (causing birth defects) that accumu-period~ "epidemiological evidence"'
latesmainliy in fish. Even after lowering, wouldd consist of aseries ofdisastersf acceptablee limits
of PCB,, the FDA haseontinuing Ibng.g afterr a substancewasadmittedlthateatingcontamibatedlfirshis.
Q banned. M'anyscien¢ists8eelwe'reinfor
still not safe f'orchildrenand "women of ~ a lot of such evidence soon,, due to thee
childlbearing age". And based on re-~A unthinking, uncontrolled outpour of'
centt studies wPoich.havefound PCB in 0) chemicals since the 1960s,
both the human embryonic fluid and pla-rQ Says Dr. Bruce Ames,.Universiay of'
centa at levelss many times higher than 0) Californiabiochemist, expert' in the field
what's considered safe, a Unirversity of~ of.carcinogenesis: "'Most.ofusare:walk-Wisconsin:
parhologist, Dr. J'.R.. Allen, ~+ ing around.withlittletimebombs tickingg
has said that "women who plan too have away insideof us...
children had best discontinue eating Relax.. As ACS1s Dr. Hammondd
fish." (Italics added.) says,."IOfl:percent of the people will die
Here's what ACS's Irving Rimer anyway, and there's no way in the.fore-saidin response too a question
abourt seeable:futuretoprevenrthat."
Reprinted Courtesy New Times Magazine

/
~ly ` ay Ruth Rosenbaum
,ed Courtesy. New Times R4agazine
~
With the billion-dollar
support of' government,,
industry and' a cancer-crazed
public, the cancer establish-
ment has set up a very privatee
practice - specializing in
benigm benefits and malig-
nant negllect
t was another war to end all
wars . . "A national~ crusade,"
Congresshad resolved, "tobe
accomplished by 1976 in com-
memoration of the. 200th anniver-
sary of our country.. . .
Richard Nixon launched the. "all-
outt assault on cancer" with the National
Cancer Act on December23:, 1971in-
tending to trigger "the.samekind of con-
centrated effort that split the atom and
took mam too the moon." With the gov-
ernmentt division-the. Nationall Cancer
Institute(NCI}-at the front:linereceiv-
ingan immediate doubl ing of funds and'a
revamped administration directly re-
sponsiblee to-the president. Nixon called
for participation by priivate:industry and
research, Ilabs,, and for the enlistmentt of
the American,Cancer Society. (the largest
pri~vatefy funded health agency). We
wereat a point in cancer research, Niixon
said, "when problems begin to break
openand results begintopourin.. .. . , "A. bunch of' skitl" was. Nobel
Laureate James Watson's private. opim-
ionn of the National Cancer Program;
more restrained before. Congress,, he
callbd the meetingg than drew up the 3-
volume National Cancer Plan "a
soporific orgy;" producing,no "promis-
ing.feads" asirclaimed,s but:"onl17. delay-
ingactions"-withtheg main research
thrust toward "just much more of what
has.already shown itself unlikelyy to cure
a majorcancer."
Creating a super-administration to
dole outt millions to afewpopular re-
search areas and forr frantic construction
of facilities, with so little basicc knowl-
edge of cancer, wasAike trying "to put a
man, on the.moon ih 11920,.before missiiles
were invented . . . [by givingl) com-
tractss to cannon manufacturers, ladder
builders, andl many, manyy administra-
tors..,, buu [Iwithf no support for mis-
sile research.,"said Dr. Ruth~ Sager,
Chief of'the Cancer Genetics IDivisionat
an NCI-afBiliated cancer centere ffive years and $4 billion:later,.noth:-
ing has changed-neitherin research em,-
phasisnon in cancer s grip on American
lives.. Yett thee cancer generals' yearlly
proclJimations of'.. "great strides" are
louder than ever.
The NationallCancer. Institute;, with
hundreds of millions oftaxpayers' doll-
lars,, and the. American Cancer Society,
with; millionss contributed in good faith
by a hopeful public, serve moree to bolF
steu the status of cancdr's current ruling
class through.earefu7ly distorted facts-
"careful public relations," as Dr... Waln son~ put it-than tooptimize.the chances
for real progress agaihsnthe disease.
The U..S. stilll holdEtthe record for
cancer incidence-SO percentt moree than
the world average-while the chance f'or
an American to survivee a cancerr inva=
sion has not increased more than II per-
cent since the latee forties. And this, de-
spite improvements inn earlydiagnosis
and'd refinements in surgery, chemothera-
py an& radiation therapy-the only
hopes that the American Cancer Society
and'the National Cancer Institute dangle
before thepublice
flc d'allar DumD
SinceNCI wasfoundedl iit 1937'
(largely thirough: ACS lobbying) as thee
first of the Nationall Institutesof Health(NIH);. itspoliciess and narrowliy definedl
researchh priorities havere8lected thee
opinionsand ambitionss of the medicall
professionals-gynecologists, surgeons
radiologistsand.pathologists-whos dome inatethe. scientific half of. the ACS gov.erning~g board
(many of whom serve oni
ihflluence and placement onn the Insti-
tute'ss twoo major decision.making bod-
ies: the three-member President's. Can-
cer Panel and the 23-member National
Cancer AdwisoryB'oard. And'' thee new
budget-approvall proeess,, bypassingg the.
National Institute of Health's. complexx
revieww system, has broughat funding
from $230 million in197D up to, $g19mil-
lion for next year-an unprecedented
amountfor a single health institute, near-
ly one-third of thetotal'. Nl H budget.
"They've [ACS]turned NCI into a
dollarr pump. ..." says a: member of the:
House Appropriations Committee,
which okays funds for NCL "They run
the whole program,, the moneygoesy where they want it togo-"IMeanwhile',o many concernedl top-
notchernployees.have lefu NCI. in frus-
tration because. "nothing ever getsdone";:officials.with corporate and insti:-
tutionalloyalties betray public interest,.
Who's doing what
research is so far beyond
NCI monitoring capacity
that some researchers do
unrelated work with
government money
and millions of dollars are consumed by
research tha[goest virtuallyunre viewed.
Some of thee programs.are reported-
lyy so ill-conceived and irresponsiblyex-
ecuted-cl'oser to publicity maneuvers,
than real strikess againstt cancer-thatt
they've.ledto coverups among the self-
monitored, ACS-controlled clique that7
dominates NCU policy and funding:deci-
sions. "Thelittle. Watergate that broke
before.the big one," is the way one high-
ly respectede empl'oyee: at. NCI d'escribest he . nation'scanc er program.
N-ralad mammo9rap"
NC] committees). The most ambitious folly to date and
Foundedi in. 19113 by' aa handful of the first joint ACS-NCl:undertaking is
physicians and Ihymen dedicated too theBreastCancerDetection Demonstra-
"educatingthe.publie . . . gettingthem~ tion Project."ThegreatestPRthing:the
to seek medical adviceeardy,"' ACS'. NCI and ACS have everdone,;' former
evolved in, the1940sinto. a coalition of'. ACS President. Dr. Hamblin. Letton
medical professionalk and powerfud lay- . called'd itt in July 1976, even after it had al:-
men from~ the top~ strata of industry.,, O, ready become clear tu many scientific
busihessand the Republiican.partyn who. ~. expertsthatthe:mammoth.screeningpro-
tailored public education programs to~A gram., involving 270;00& women aged
suit the needs of fund-raising crusades. ~, 35-70..hadlbecome the "scorched earth"
It wass a small groupof ACS mem- tp phase of the cancer war.. Because: ofbersand'.associates.who
hand'crafted the. ~ abuse of one off three screenimg tech-
National Cancer Aet, insuring,thatg gov- %J niques-mammographry (breastt x-ray)-
ernment funds : forr the National Cancer C!1 there is a significant:risk that more wom:-
Ihstitute would boost their self-serving
strategies. Withtop. NCII appoinrments
no longer subject toreview by Congress
or byy the Department of: Health, Educa-
tion, andl Welfare ACS was guaranteed
en under 50' will die from cancer becauseof'the.program.than, will be saved by io..
And then theree iss thedarke horse horror
which materialized tbisfall (thoughsome. ~
scientists had warned about apossible
R

it71' tetl you . s°' goung' wrong*
~ ~sore that d~oeseno~ 618dderfra6its.
9: Thicksun endngor 1Ag or d'si:harge.
S,Inbr~atorel'µ~e e,.
insw floonordifh~f~, .6-©hvibus: kan
~ alVaggi~ng eougfgor j
ofe,
auea ar enes
s~You ~h »reming:sighaf
fslseaferd~tor.Ifit'sa '
~~rfan't Yolu~,gtell
iveh,m,
rt'6. whatefp; Deon'f he afraid',
th . Youdontk
at
n
can$~~~ -ow
ACS's power and
affluence dependd on ~ its
being, recognized as'the sole
dispenser of cancer
information and hope
lion from,whau most scienistss agreeis.an
urgent need to pursue innovati.+e,.radi-
cally new ideas in cancer research..Criti-
cizing NCI's research program, 1975 No-
bel Ptizee winner Dr. Howard. Teminclaimed there is tooo much emphasis "on
directed research that assumeswes know
how cancer is caused andcan bee
cured! .,, and thart puts large sums of
money ina feww places to pursue only a
few ideas."
But the people who carefullyengi-
neened the National Cancer. Act and
NCI`s increasingly largesums: have too
much at stake.personally and profession,
ally t'oo allow competition withtheir few
ideasand'.assumption s.
Take chemotherapy-am ACS fa-
vorite. Nott onliy does ACS'co-own thepatent for oneof'e the most frequently
used cancer drugs-5-fiuoroucaril-but
Mary Lasker.. a f:iend'd of Dr. Sidney
Farben, who pioneered the first chemo-
therapeutic drugs in thelateforties.e has
pushed NCI for years tofund amassive.,
impractical "Chemotherapy Screening,
Program." designed totest at random
some 50.000 chemicalsa year for their
effectiveness againstt cancer:.. Though anindependent commission described theprotect as.
"utterlrywithouC scientific
mertt!`asearly as 1965, NCI's firsrbudk-
etunder the National Cancer Act'(1972)~
tripled funds for the.screening.project.
I m. response to an ACS/NCI "educa-
tionalf' claim that "about one-third of alll
cancers are responding,to chemothera,
py," Dr. Marvin Zelen of the Eastern
Cooperative Oncology Group,. aa groupp
which, specializes in clinical trials of
dtugsand: othertherapies, often funded
by NCI, laughed: "Itdepends on whar
you meanby 'responding."You have too
distinguish between cure and a werytem-
pomryresponse-I would.hesitate to say
anything I ike that:"
For some raree cancers, such aschfldhood leukemia, Hodgkim's.disease,.
Wilm:'s~s tumor, chemotherapy can in-
creasesurvival tiime, but most ofltenonlyar the.risk.of devastatiing side effects,. in+cluding an
inereasedd chance of develop-
ing a secondcancer after adecade.
Important questions about the value .
of conventional treatmen0 for certaim
cancerss havee bee n raised by recentt stud'-
ies. One, reported in Lancet, the Btitish~
medical journal..in December 1975, 'comcludesthan "moo immediate treatmenn
proved a significantlyy better policy for
patients' survival and forthequaGOy ofremaining ,life'for inoperable carcinomaa
of the bronchus: ; and another, which,
Dr:. E., Cuyler Hammondl ACS Vice
President for Epidemiology and Statis-
tics, described to me, involved "a re-markable number of patients diagnosed.
with Breastt cancer in whom no evidence
of breast cancer could be found later,
even though theyreceived.absolutely no,
treatment."
Opeo soasos oo quacks
B oa s t i ng' t h e"l arge s n. repo s i t or y f o r
unproven methods information in thewordd,"ACS's Committee on Uhproven.
Methods off Cancer Management workshand-in-hand with local and state medi-
call soc.ieties and with the American:
M'edicalAssocietion's(A~MA). Commit-~
of' ~'
tee on Quaekery,, forming a networkk
~
vigilantes prepared t;o.pounee on anyone
who promotes acancer.therapy thactuns~
against.their substantial prejudices and ~
profits.T
Indiscriminate inn its"quack. at- 0
tacks,°" the ACS committee-whose
members, half laymen, half professionr
a15,, includee representatives ftomi the
Food and Drug Administration (FDA).
NCI andl AMA-has ruined promising
careers and keptt potentially valuable
ideas f rom being seriously tested.. (Their
rationafeis that these ideaswould Ibre
patients's from "known cures" and
"provenmetfiod§. ")
Protesting ACS's "negativerole" in
thiss area, one establishedd cancer re-
searcher said'., "Theree have been any
number.of peoplewho:have been unable
to, obtai~n grantss and/or have been
scornedl by theircollkagues over the
years for concepts that have now be-
come accepted in the cancer fieldi"
An exaruple:. Dr.. Bradford Coley'ss
bacterial toxins treatment, whose two
basic principles, immunotherapy andhy-
perthermia are now being actively in-
vestigated by the medical establishment,
has just.been removed from th e1 hdex.of ACS File Material. on. Unproven Mleth-od5of Cancer
Management. As Dr..Sid-
ney Arje, ACS Vice Presidenrfor Pno-
fessionalEducation and staff member of
the Unproven Methods Committee, told
me, "With all the current ihterest in~ im-
munotherapy an&work: with such things
as. BCG1 Bacil le . Calmette-Guerin, a~ tu-
berculosis vaccine thoughtt to stimulate
the.bodr's immune system to fight can-
cer],.it'sall sosimilar to what Colegwas
doing that it wouldn't be fait.to keep him
on the lisn."
How reasonable... Actually.,, it was
only at the request of Dr. William Regel-
son.. foumerly Chairman of the Division
of Medical Oncology at Vitginia Com-
monwealth Uhiversily. that action was
finally takenL . Hadl Coley's work been se-
riously investigated att the timeeven if it
were nott i tself. a'`sol ution," 40 ~years. of
immunotherapy research would have
been gainedl_ and many lives, perhaps,
saved.
Such thoughts off wasted potential
don't phase ACS.
When I askedi Dr.. Arjee about am.in-
R

While grant applications must pass
through the NIH peer review system, for
contracts "there is practically no re-view," said a, scientist whose institute
receiveslarge sumsof money from NCI
for contract research. "And there are
manyy areas where.a researcher canapply.
Bor either a grant or a contract to: do the
same thing."
Apparently those with weak.propos'-
als go for thecontracts.. In the casee of
the virus's program the Zinder report
claimed that "lessthans half of the.con-
tract proposals would have been ap-
proved if reviewed by areal grantt peer
review."
No one yet knows exactly what.is
going on.at Fort Detrick.. the former bio-
Not ewen the most simple
precautions were taken t'o
keep x-ray exposure to al
minimum
logical warfare researeh, center in 'Fred:-
erick. Maryland. part of which was
transformed into a cancer research cen-
ter after Nixon's emotional "swords into
plowshares" speech. Speciali¢ing in vii-
ral oncology, and in.researchandltesting
of possiblecarcinogens,e the:eenter,e manr
agedd by a.divisioniof LittoniIndustries.,
has received a total of $119~ million since
1972'-thc largest amounTfor a single con-
tract'. in the: entire program:.
"We've wasted a. fortune on that
system; absolittely nothing has come out
of im." said Dr. Garb. "t was one of the
mosu enthusiastic supporterss of the Cen,
ter,, and I haveto say Itm sorry now. We
canftt even tell whyit's.not working-but
say you haveae handfull of quarters and
put them in a popmachine. If you don't
get any sodaafter the fifth quarter, you
are entitled to say thee maehinee is no
damned good- even if you don'tt know
what's wrong with it." Next year's
budget deposits another $24 million
quarter in,Fort.Detrick-.
"If whatt the General Accounting
OtTice. (GAO/: has apparently'foundlinre-
viewing the Eppley. contract is an indica-
tiomof how other contracts and research
efforts att the Cancer Institute have' been
administened I think Congress has no
choice but toeonsider'a.complete.over-haul of the Institute." reported Con-
gressman David Obey.
Eppley Institute'.ofOmaha. Nebras-
ka, which has received.$20 millionfrom
NCf in the past eightt years has been
charged with using. NCII contract moneyy
for non-related projects, and for charg-
ing the government for supplies used inn
industrial projects-includ:ing 53.00t1(t
laboratory test animalss which Eppley.
elaims were destroyed.. Bun the stickiest
question raised by the GAO'findings iss
one of conflict of interest:: EpplegDirec-tor PhiJippe. Shubikk has been, an influen-
tial memiber of the National Cancer
Advisory Board.since its inception, andl.
an the' timeof the alleged contract io-
regularitiess wass chairman ofthe: NCI
subeommittee on Environmental Carv
cinogenesie. Ass such:, he was themem-
ber mostresponsiblet for overseeing thee
division that awardedl Eppleyy contracts.
Ironicallg, inn defense ofl Shubik,. the.
Cancer Letter,, an NCI-affiliated weeklly,.,
states:: "Why Obey has singled out. Shu-
bik ass a.target for conflict of interest
charges is~ a mystery.. Nearly every scientific member of:the Boardl,..the Pres-
ident'sCancer Panel, and the various
adNisory committees could be subject tosuch'charges . . ..
Slatihlicall ahsIraOous'
It took. Irv.ing. Rimer, ACS Vice
President of Public Information, aloneamong,the top ~ACS executives, to crackk
the cheekyy new statistics riddle in ACS's1975 annual report: "Cancer incidence,"
it' teased. contradictingg every other
sourceon thee subject. "has declinedd
slightlyinthe last 25years,"
"You have too understand some-
thing," Rimer explained~.. "Somewhere
around 197?or'73, westopped.inoluding:
in our calculationsail skin cancers ex-
cept melanoma..the only one that-sfatal.
and al so irrsitm cervical cancerar, because
many experts don'tt consider these to be
cancers.at.all. Sineee together they ac-count f'ora.large number of cases..that
couldd be whyy the incidence has gone
down."'
No wond'er cancer is "one of thee
mosn curable ofthemajor di,seases in
this country," as The FlopefufSide of
Catmer.. ACS's basicc public educati on
primer. st;ues.. Those skin and[
cervicah
cancers. unfit for the incidence figures,..
are greatt for thegrand'e tall!y of
"7.5p(t,tA)0: Americans alive today who
have had cancer." towhom ACS points
as.proof of the success of their "eancer,
awareness"campaigns and themethod5e o ftreat ment't they promotle..
77houghtheir own chief statistician
reportedly suggested thact the.figure be
droppcd because of its unreliabledata~
baseACSbrazenly upped it to = million.
in 1976.
Ift is this type of outright dishonesty
and statistical legerdemain thar.supports
the country's system of orthodox cancer
treatmennand leadsahe public to befievee
that thee medicall establishmentt is well om
the way to controlling cancer.
-'Today'. one: outt of three cancer pa-
tients.isbeing saved', And it could be oneine
two, if the disease.were.detected early
and treated'.promptly," This, the central:
hope-myth conjured upby ACS/NC[,C
has been retold since.1956:. Adding~a final
flourish, this summer, Dr. Lee Clark
(ACS Presidenn and NCI"s: senior
scientific member of. thePiesident'sCancer Panel) predicted the advancee to'.
"one in two" wouldl come "within the
next five years."
But we have yet to see.even aone-in-three survival rate that has been based~
on, a fair representation of the American'
popularion. Non-whites, for example,,
whose cancer death rate is higher- a nd.
much higher for males-thann thatt ofl'
whiteswere virtuallyi'eft'out ofltheone-
in-threee calkulations, while those pa-
tients included (,only 3 percent. of thee
country's total ) weree treated at largee pri-vate andluniversity hospitals wherepre-sumably they
were receiving, thebest'
possiblecare and treatment_
It iss rarely mentioned'd in ACS/NCC
educational material that "saved" refers.
only to being alive five yearss afterr thee
time cancerwasr diagnosedl... not to long-term survival as most people would in-
fer.
Even without alfl these qualifnca-tions. the fact that "one inn three"sur-vives today is noo
triumph... People diag-nosed as having cancer in 1948-52'al-ready had a32 percent.chance
of.surviv-ing:.f and. "the commone st cancers,"' ac-cording to Dr. Donaldl Gould, NewScientist.
editor, "are asresistanc to,
treatment as they were 40 or 50 yearsagu."
Still- orthodox treatment methodsare peddled to the public and to Con-gress as "known cures,"
diverting atten-
You muau"V 11111 cuall
harc hpcast caaccc?
There. had been, . early warnings.
Severadl scientists, including one of the
world"s'.leading pathologists, had writ-
ten that mammography as a screening
technique might detect breastt lesions
tooo small or too uncommon for most
pathologiststos correctlyy identify as
malignant or benign..
This September, ann expert pa-
thologist review committee reported
that out. of the. 506 "minimal cancer"
cases they studied, at.least.ti6, possibly
88 were entirely benign'. Seventy'-one
off the women involved have had com-
plete mastectomies, mosrof them radi-
cat Though there is data to:suggest that
even morewomen have undergoneun-
necessary breast surgeryy as a result of
the ACS/NCI breastt cancer screening
program. officialis have been, scram-
bling alioutt madly, trying to prove that
"there may nott have been any un-
necessary masttctomies att all."'-RIR,
R

the NCI.Director: ' Wedon'tJike your di-rector of such and such, somybe: you.u
should!think about.gettinga newone.' "
"AA red herring of Yidiculouss propor-tions!" Benno Schmidr.. a WaI1:Street. in-vestment banker.r
who has been chairman.
of' the: President's Cancer Panel, the
apex of NCI's power structure, since
1971, spokee in an angryvoice of the
nasty suggestions of an, "ACS-NCIlink" brought upat the House prelimi-
nary oversight hearings on NCI!this sum-mer. "I never even heard firomthe.
American Cancer Society-in five years
noo one from theree has even calfed' me."
Hasn't Mr. Schmidt been aware of
ACS President and former Vice Presi-
dent:Dr: LeeClark, who has been serv-
ing.g with hi m ion. the President's Cancer
Panel for five years; or of ACS past offic-
er director and Pennwalt Corpbrationdi-
rector Dr. Jonathan Rhoads, who has sat
nexat to: himm at NCI'ss monthly National
Cancer. Advisory B'oardd meetings
(Rhoads is the Advisory Board's.chair-
man)t or of several other ACS members
who serve, or have recently.servedlon
the. Advisory Board or on important NCI
committees-includingMary Lasker,
Emerson. Foote.. Frank Dixon (consult-
°Thelittle Watergate
that broke before the big,
one;" is how one NCI
employee describesthe
nation's':cancer program
ano for Eli Lilly andl Co.)) and Elmer
Bobst (chairman of the Warner-Lambert
pharmaceutical company and old Nixon
friend and'd campaign.contributor)..
No one: controls Benno Schmidt,
butt he would'd not have been singled out
for such an imponantt position if his
views did nott coincide with ACS intar-
ests.. When Senator Ralph. Yarborough
(the original sponsor of the National
Cancer Act legislationi appointed a panel
of consultants to make recommend'a-
tions for.the act, names were: "suggest-
ed too him" by Mary Lasker and an ACS
Iobbyist in Washington, including the
name of'~ Benno Schmidt, who became
chairman.
Considering the act's provision that
officials be appointed by the President
withoun amy outside review, andlthe fact
thatt both~ Mary Lasker and. Benno
Schmidtt were frequenn visitors to Nix-
on's andlFord's White House,.it was mat-
urali thatt memberss of the panellof con-
sultants and other. ACS.favoriteswoul!d
fall:intoposition on NCE's National Can-
cerAdvisory. Board, which has final say
as to.where research funds go,
Also: monitoring of: NCI activities
under the actwasleftt to the 3-member
President's Cancer Panel, whichh is to
say, to Benno:Schmidt..
"Heruns.the whole Advisory Board
and President's Cancer Panel," said an
AdMisory Board member. Asked.at the
oversightt hearingss howthePresident"s
Paneldoes: itss monitoring, Benno
Schmidt replied, "If instances comee to
my attention,. I raise thosee questions,
discuss them and satisfy myself that
whau wass done was: done for good rea-
son.."
arly 118010311: No fala
~We emphasizethat'.a.majmrpercentageed.example:of the rewardsof.early di-
:of cancers cambe curedthroughd earlyagnosiis, supposedly"'largely nesponsi-
diag>tnsis:. ble for a 65:percent.d6cline in mortality
I
-Walter]ones,.ACSWice ratef'rom.uterine.cancee." Buttheun- ,
Presid'ent for Public Education, distorted statistics dori t support that.
ACS'sIDr. Hammond explained in aJ1970.
Go beyond ACS and NCI publicc paper before the British Association
relations divisions and you find that the for Cancer Researchrthat "the decline.
'frailtyof currentmetPoods.of earlydiag-in uterinee cancerr began before the in-
,nosisas a hope against.cancer is com- troduction of cytology [Pap test]"an&
limonn knowledge. "There isn't onee thatthePaptest"didnot.playthelead-
t
shred'
of evidence that early diagnosis ing role during the years when the larg-.
I
doesany good',: except:perhaps in.theest.declinetook:place,"
Icase: of breastcerviaw. andlbladder ean-"There.is a great deal of overstate-
cers," said' Dr. James Peters, former ment about: thee vallueof earlydiagmo-
NCIiDirector of the Divisionof:Cancer sis," says. Hammond., "I'i m stull trying. .
~
Causeand.Preventione after25yearstotindsome.deHiniteevi-
Dr. Frank. Rauscher believestlhats demce. ...
"evenwithcervicalandbreasncancer, Actuallly, earlly diagnosis may
therei~snogoodevidbncethatlbngevi- serve to artificially boost survivall
ty is improved by early detecrmtes. A 11956'6 study byHammond.
tion... .." showedd than it. may extend only past.
The Pap tlest-which: ACS takes surviMall time, timee when thee patient
credit for popularizing-iis themost.cit- would have.beeni alive anywa .-R:R.
Apparently he is easily satisfied.
The "NASA-style management,"'as hestill dares to refer to the new. NCI ad,
ministration, spawnsterrible:inefhcieney
and waste-partlyy becausefavoritism~
takes.precedence over fitnessin fillingg
top positions.
When, 253of the professionals on
the NCI staff weree asked in, a: 19744 sur-
vey to indicate probl'ems adversely
affecting their job performanceauthe Iln.stitute,. half cited "widespread lack of
confidencee in the scientific acumen of
the decision-makingg hierarchy" and'' a.a
third complained of the. "shortage of'
qualified scientific and technical'personnel.
A, ncw, ive o!. Mcllaro
With so few in-Bousescientists, the
new millions were dished out.to private
institutes and industries,.commercial re-
search labs and largeuniirersities. There,
who's doing whatt research is so far R
beyond NCI monitoring capacity that
some researchers do unrelated work
withgovernmenrt moneywhile others re-
ceivemoney only by the grace of the.
"excellent writing and prepanation" of
professional grantsmen., which~ commer:-
cial organieations can well afford, and!
which has. "little or no relevance to the
kind of laboratory research they db>" ac-
cording toDr. Solomon Garb, Scientific
Director of the American Cancer Re-
search Center and Hospitallin Denver
Colorado.
Itn effect. the influx. of funds.initiat-
ed byy the National Cancer Actt created anew typeof welfare system-as Dr.
Watson described it, one "moree palat-
able to this administration because the
recipientscannot solely sop up beer andd
watch, TV-. but instead'l will wear eleamr
white lab coats and look into cancer
cells. Nofu being trainedd for' thee task,
however, they are most'.unlikelry to fath-
om the.inner workings of the.cancer'cell,
and in a ghoulish way will be forever as-
suring the. contlnuatiom of their job de-scriptions."
The mainstay ofNC1's welfare:sys:-tem is contracu research.,, which afisorbs.
40.6 percent of all its.research.funds, and
invitesabuse and poor quality work. For
example:
The Special. Virus Cancer Pro-
gram, which depends mostly on contract
research, has been glutted witivmis-used
funds-nearlyhalf a billion dollars to
date-since its inception in 1964.
"A self-perpetluating bureaucracy.
full of conflictss of ibterest:, its existence
justiflyingits further existence . was the way a 1974 reviewby outside
scientists (the Zinder report) character-
ized the Special Virus Cancer ProgramL
Those running, it, the reportt charged.,
come "from a. narroww section of thee
scientific community, and receive IargCamounts of the money theydisr
pense. . ..

stance where a reporter had prove&that
promising elementsandl supportivee
quotes..abouts a particular "unpnoven"'
cancer therapy had been omitted in.the.
"quack file" write-up.. hee said, "I don'tt
remember the details exactly-but basi-cally. C mean evem if we were that nega-tive, that.initselfis
valid. Our purpose is:.
too keepp these unproven~ approachesaway from the public., especially as they'
become popular-that's whem they'remost dangerous. "
Most dangerous to whom7It seemsthat thee restrictivee authority ofthef lIn-proven Methods Committeee
is designedd
more toelimimateanythreat to ACS'9to-tal dominance off cancer management
and cancer publicity than.to protect the
public.. For instance, I was astonished tofind.among some documents on unpnov-en method sa l ength
ymem:by AlanDa-
vi9~ . ACS Vice. President for Governmen-
tal Relbtions,, warning division execu-
tives ofian individual fnom, a small pri-
vatecancer instimtee whoo was: asking
mayorss and governors toproclaimi a
"National Cancer Day"-notrthe kindlof
thing you'd imagine could killl a lot of
people. In fact, all he: was advocating
were medical check-ups and' early diag-
nosis.
"If a city or state.in your division is
involvedl," Davis wrote.,."see if itis pos-
siblee toFiavethe Mayor or Governor 'de-
proclaim'. ... Being fori moree aware-
ness of cancer is a good wayto get.favor-
ableattention,.and.the cause is exploited
byy many for various reasons, often with
considerablee success."
Apparently. ACS'.has,had the most
success.
icrmiaal oplimiDm
"There's something I don't think
people understand," Dr. E. Cuyler
Hammond sighed. "Say something, in-
creasess yourr risk of dying of bladder
cancer (we'd just been talking about sac-
charin whichhas,beem shown in human
studies mo cause a BO percent increasein
bladdercancer, inmen) . . .
"Look; says Dr.
Hammond,"if you die of one
thing, you can't later die
of somiething else"
"Well- ifl it imcreasesyour'risk of
dying of bladder cancer, it decreases
your risk:of dyingof cancerof the.pros-
tate: cancer of the.lung, cancer of the
stomach, or any other f'orm off can-
cenL. .. Look, if, you die off one thing
you canPtlater die of something.eise, do
you follow me?"
Sure. While monopolizing and bung glingthe areas of research and trea4
ment., the cancer establishmentt mini-
mizess the importance off cancer preven-
tion to avoid steppingg on industrialized
toes.
A major source of support for ACS
D9qlrkaaE bcsC?
WhileACS:'s self-proclalmed'. pur-pose is "tado everything possi-
ble ... .. . tohastem the elimination of
cancer as a threatt to human life, and'
well''.-being," theiv larger commitment isto.the supremacy and absolute.freedom,
of'f theindividual physician, including
the freedom to.administer dangerous or,
carcinogenic drugswitfiout thee pa-
tient's knowledge.
Consider the use of'f estrogenss too
treaut symptoms.of inenopause:. Studiess
linkingg estrogens withr a greatly in-
creased risk of d'evelbpingg endometrial
cancer (a form.of uterine cancer) have
led some experts to cite the drugsass the chief responsiblee agents in a 50'per-
cenn ri~sein uterinecancer between11469'and 1973. The.FDA,recently ruled,
that a: warningg about tkecancen riskk
must.be includedlon package inserasfor
the womenusingn the drug as well as for
pharmacists and physicians.. Before,
this ruling. (Oetober 17),. 1 asked Dr.
Sidney Arje, ACS Vice. President.for
Phofessional Education,, if ACSbe-lieved that women should be told aboutt
the potential riskorif inention~of it wasincluded in any of ACS.'ss educational
material on uterine cancer.
"No," says Dr. Arje. "Thatt
would beinterfering, with the physi-cian-patientt relationship."
Interestingly, thesee exactt words
wereused byttie American Medical!,
Association (AMA).,., and recorded in
the 1Federall Register; as an argumentt
against aproposal that thee risks in-volvedd in taking birth control pillss belistedlon the patient
package insert.
When I asked Dr. Ar~jeif'ACS:pol-
iciesever' differed fromm those. offtheAMA,. 1 wass immediately assured,.
"Not in any instance II can think of.
. The ACS,. AMA, and American
Collegee of'Radiologists all use the same
technical staff."'
llCaving, called several of the58ACS~ lbcal'otHces, aswells as the nation-
al office, askingthe.public information
representative about various subjects,
including estrogens and'd other con-trorversial I drugs,. I was never given . any
iioformntion., butt was told "Ask your
physician:° or°If~. your doctor haspre-
scribed it.,, you shoultln't worry:" Thee
factss i ndicate you should worry:.
0 In 19755 moretham:500,000 pre-
scriptionswere gjlvento pregnant wom-
en for progesteronee drugs, known to
cause.birth defects.
when it began fund-raising activity in:
1945 came from industrialists.enlisted by
George Stringfellow, then Senior Vice
Presidentt of Thomas A. Edison,fndus-
tries, Since then, manyhave become
fn one necenrt year, between
40',(q0 and 60,000 . women received pre-
scriptions for DES too prevent.t miscar-
riages-a drug which:caused~ an.unusu-
al number of cases of vaginal cancer iin
the.daughters of women who took itiin
the:fifties.
Depo: Promera,. a drug approved
by. FDA.A onlyy for treatment of a rare
kind of uterine cancer, is being pre-
scribed by d'octorsasa contraceptive.
Amongg other dangerous side effects,
there isa possibility that it`may cause
breast and cervical cancers;,85percent
off women soo far contacted by a con-
sumer groupin California had not been
infortmed of'the side effects nor thau it
was being sold to them fbr ann unap-
proveduse.
While sending cancer patients and
the general public to theirl'ocal physi:
cians foranswersto~ most questions,
ACS public information reps actuaBy
discourage them.from,seeking out can,
cer specialists (oncologists),. andfrom
going to: NC1-fundedd comprehensive
cancer centers, wPoichACSlobbied for,
andd where their chances for survival
are best-
What does ACSdo,S then, to
educate the primary physician with
whom most of uscome in contact?
°Our doctor education is not so
much a matter of transference of
knowledge, but ratherof motivation,"
Dr. Arjeexplainedl. "Ws not directed
toward'.teaching the doctor what he has
to know but toward getting him.to use
what he already knows."
The education program d'ependk
chiefly on theCaJournal': A Cancer
Journal'for CRinieians which reaches
400;0p0:physicians,0 and'whose primary
goal, according toArje, is "to keep the
doctorhopefullaboutcancer."
"14+e've:found a wonderful educa-
tion opportunity with cancer." he con,
tinues. "You don't really havee to do
anythingg butt use the name 'cancer'-
there's a subliminal effect-Evemif the
physician doesnit goo to our confer-
ences, it's enough that the Ca Journal
crossess h is desk or that . it's in the hos-
pital at his station~ whenhen walks by-
something will sink in."
For thismagical osmosis com-
bined with the public.information and
educatiom programs, ACS spends
about $30 millionannually-then same
amounrtheyt spend on cancer research.
-S.R.
R
